Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -438,160 | -363,806 | -294,114 | -112,687 | -251,576 |
| Depreciation Amortization | 86,301 | 72,677 | 60,532 | 9,158 | 30,952 |
| Income taxes - deferred | 5,872 | N/A | N/A | N/A | 8,829 |
| Accounts receivable | -10,483 | 121 | 1,860 | 2,346 | 11,525 |
| Other Working Capital | 36,911 | 35,359 | -29,495 | -13,982 | 20,427 |
| Other Operating Activity | 125,488 | 125,944 | 104,853 | 33,611 | 81,204 |
| Operating Cash Flow | $-194,071 | $-129,705 | $-156,364 | $-81,554 | $-98,639 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -495,571 | -306,319 | 61,388 | -73,817 | -337,798 |
| PPE Investments | -17,843 | -11,491 | -8,183 | -6,023 | -13,757 |
| Net Acquisitions | N/A | N/A | -2,422 | N/A | N/A |
| Purchase Of Investment | -10,000 | -10,000 | -10,000 | -10,000 | -4,000 |
| Purchase Sale Intangibles | -38,134 | -25,618 | N/A | -11,434 | -31,682 |
| Other Investing Activity | -38,134 | -25,618 | 0 | -11,434 | -31,682 |
| Investing Cash Flow | $-561,548 | $-353,428 | $40,783 | $-101,274 | $-387,237 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 650,000 | 650,000 | N/A | N/A | 279,267 |
| Debt Repayment | -46,162 | -46,162 | -25,000 | -5,000 | -11,667 |
| Common Stock Issued | 103,574 | 63,485 | 46,401 | 23,490 | 345,609 |
| Other Financing Activity | -38,697 | -38,697 | -35,829 | 0 | 0 |
| Financing Cash Flow | $668,715 | $628,626 | $-14,428 | $18,490 | $613,209 |
| Exchange Rate Effect | 7,688 | 449 | 442 | -403 | -1,303 |
| Beginning Cash Position | 295,528 | 295,528 | 295,528 | 295,528 | 169,498 |
| End Cash Position | 216,312 | 441,470 | 165,961 | 130,787 | 295,528 |
| Net Cash Flow | $-79,216 | $145,942 | $-129,567 | $-164,741 | $126,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | -194,071 | -129,705 | -156,364 | -81,554 | -98,639 |
| Capital Expenditure | -17,843 | -11,491 | -8,183 | -6,023 | -13,757 |
| Free Cash Flow | -211,914 | -141,196 | -164,547 | -87,577 | -112,396 |